Scientists Try To Develop Alzheimer's Therapy For Reduced Brain Blood Flow

Scientists Try To Develop Alzheimer’s Therapy For Reduced Brain Blood Flow


By knowing the culprit behind dropped blood flow in the brain of individuals suffering from Alzheimer’s, Cornell University’s biomedical engineers have made potential promising new treatments for the disease. You are aware of that dizziness you feel when, after lying down for a long period you stand up a little too swiftly?

That feeling is a result of a sudden lowering of blood flow towards the brain, a drop of almost 30. Now imagine living every day every minute with that level of lowered blood flow.

Individuals suffering from Alzheimer’s disease do not have to picture it. The presence of cerebral blood flow lowering in Alzheimer’s people has been recognized for decades, but the exact association to damaged cognitive function is less known. “People possibly adapt to the lowered blood flow, so that they do not feel dizzy every time, but there is clear proof that it affects cognitive function,” claimed associate professor at Cornell University for biomedical engineering, Chris Schaffer, to the media in an interview.

On a related note, 3D Signatures, a Canada-based firm, have invented the TeloView Technology. This technology or rather a system is a platform for software that can examine telomere patterns present in cells in order to analyze a disease. The firm lately declared the outcome of a clinical research, on the verge for publication in the Journal of Alzheimer’s Disease. The report claims that TeloView Technology could reportedly recognize Alzheimer’s disease and forecast if the disease was severe, moderate, or mild, on the basis of examining a cheek swab sample from patients.

Telomeres are formations that guard the peak of our chromosomes. The company has studied the 3D structure of telomeres in diseased as well as healthy cells, keeping in mind to develop diagnostic techniques. They have examined telomere structures in Alzheimer’s disease and in different cancers.